Premium
The thorny path of clinical pharmacology
Author(s) -
Gross Franz
Publication year - 1978
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt1978244383
Subject(s) - clinical pharmacology , specialty , medicine , curriculum , position (finance) , pharmacology , medical education , political science , family medicine , law , business , finance
Clinical pharmacology has not yet been generally acknowledged as a medical specialty, is not represented in the curricula of many medical schools in the United States, and is unknown to the major part of the medical profession. Outside this country, the situation is even worse, and with the exception of a few countries, such as Great Britain and Sweden, clinical pharmacology has nowhere achieved the place it should have, nor is it recognized in the way it deserves. Not infrequently, clinical pharmacology finds itself in the unhappy position of a discipline which is tolerated but not much liked and not at all supported. 14 Many reasons are given to explain this status, the most often quoted but least convincing being the lack of funds, which, even if not made available in amounts comparable to those in the United States, should be and could be found, if clinical pharmacology were generally accepted as a discipline.